Title : Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.

Pub. Date : 2021 Sep

PMID : 34080040






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 All patients with CCNE1 amplification (n = 7), TP53 R175H substitution (n = 6), and RB1 mutation (n = 4) had poor response to paclitaxel plus carboplatin. Paclitaxel tumor protein p53 Homo sapiens